Fejza, A.; Polano, M.; Camicia, L.; Poletto, E.; Carobolante, G.; Toffoli, G.; Mongiat, M.; Andreuzzi, E.
The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2. Int. J. Mol. Sci. 2021, 22, 7511.
https://doi.org/10.3390/ijms22147511
AMA Style
Fejza A, Polano M, Camicia L, Poletto E, Carobolante G, Toffoli G, Mongiat M, Andreuzzi E.
The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2. International Journal of Molecular Sciences. 2021; 22(14):7511.
https://doi.org/10.3390/ijms22147511
Chicago/Turabian Style
Fejza, Albina, Maurizio Polano, Lucrezia Camicia, Evelina Poletto, Greta Carobolante, Giuseppe Toffoli, Maurizio Mongiat, and Eva Andreuzzi.
2021. "The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2" International Journal of Molecular Sciences 22, no. 14: 7511.
https://doi.org/10.3390/ijms22147511
APA Style
Fejza, A., Polano, M., Camicia, L., Poletto, E., Carobolante, G., Toffoli, G., Mongiat, M., & Andreuzzi, E.
(2021). The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2. International Journal of Molecular Sciences, 22(14), 7511.
https://doi.org/10.3390/ijms22147511